Skip to main content
$83.96 $0.83 (1.0%)

04:00 PM EDT on 06/18/21

Incyte Corp (NASDAQ:INCY)

CAPS Rating: 3 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Current Price $83.96 Mkt Cap $18.5B
Open $83.00 P/E Ratio 38.40
Prev. Close $83.96 Div. (Yield) $0.00 (0.0%)
Daily Range $82.62 - $84.14 Volume 2,074,236
52-Wk Range $75.52 - $110.37 Avg. Daily Vol. 1,229,968

Caps

How do you think NASDAQ:INCY will perform against the market?

Add Stock to CAPS Watchlist

All Players

286 Outperform
37 Underperform
 

All-Star Players

54 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:INCY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFEBCapital (98.21)
Submitted April 25, 2017

The setback on its RA drug with LLY offers an attractive entry into this intriguing drug developer. With Jakafi sales growth (and profitability) and the potential for a best-in-class IDO-inhibitor (with data coming up), I think this company deserves… More

zzlangerhans (97.88)
Submitted June 07, 2012

Jakafi revenue of 21M for Q1 was respectable but that number will like have to go much higher before Incyte will come close to neutralizing their hefty quarterly burn. Aside from preliminary data from the phase IIb trial of LY3009104 in rheumatoid… More

NASDAQ:INCY VS S&P 500 (SPY)

Fools bullish on NASDAQ:INCY are also bullish on:

Fools bearish on NASDAQ:INCY are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about INCY.

Recs

0
Member Avatar TMFBigFrog (86.29) Submitted: 10/4/2018 9:03:21 AM : Outperform Start Price: $69.76 NASDAQ:INCY Score: -22.14

Relatively reasonable risk/reward profile in a crazy industry.

Recs

0
Member Avatar TurksFan (43.46) Submitted: 4/7/2018 8:43:26 AM : Outperform Start Price: $64.57 NASDAQ:INCY Score: -28.72

Starting my research into biotechs

Recs

0
Member Avatar ashersdad (< 20) Submitted: 1/1/2018 1:57:39 PM : Outperform Start Price: $97.36 NASDAQ:INCY Score: -68.68

It's just pulled back too far.

Leaderboard

Find the members with the highest scoring picks in INCY.

Score Leader

sara1985

sara1985 (96.96) Score: +3,069.73

The Score Leader is the player with the highest score across all their picks in INCY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
sara1985 96.96 4/6/2009 Outperform NS $2.35 +3,472.77% +403.04% +3,069.73 0 Comment
dkelleher83 37.42 3/26/2009 Outperform NS $2.44 +3,340.98% +407.95% +2,933.04 0 Comment
emmtom1 < 20 5/27/2009 Outperform 1Y $2.94 +2,756.27% +358.37% +2,397.90 0 Comment
TaooaT 93.79 5/11/2009 Outperform 3Y $3.03 +2,670.96% +357.19% +2,313.77 0 Comment
baylesbrothers < 20 6/22/2009 Outperform 5Y $3.27 +2,467.58% +357.51% +2,110.08 0 Comment
rffoss 46.89 5/12/2009 Outperform 3Y $3.33 +2,421.32% +357.55% +2,063.77 0 Comment
ovrsxdunderpaid < 20 6/12/2009 Outperform 5Y $3.35 +2,406.27% +344.11% +2,062.16 0 Comment
want2retirenow 65.31 6/1/2009 Outperform 5Y $3.35 +2,406.27% +347.59% +2,058.68 0 Comment
slimjim2005007 < 20 6/10/2009 Outperform 3M $3.42 +2,354.97% +342.78% +2,012.19 1 Comment
FoolInNY 25.69 6/4/2009 Outperform 5Y $3.54 +2,271.75% +343.90% +1,927.85 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for INCY.